For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Paratek Pharmaceuticals, Inc.

USPTO Granted Patents = 71

CIPO Patents = 5

EPO Patents = 22

Trademarks = 14

Forward Citations = 879

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Mark L Nelson (38 out of 70 patents)

Roger Frechette (21 out of 24 patents)

Beena Bhatia (16 out of 18 patents)

4. Todd Bowser (15 out of 16 patents)

5. Mohamed Y Ismail (15 out of 19 patents)

6. Tadeusz Warchol (13 out of 13 patents)

7. Michael P Draper (12 out of 13 patents)

8. Laura Honeyman (10 out of 10 patents)

9. S Ken Tanaka (9 out of 11 patents)

10. Peter Viski (9 out of 10 patents)

11. Jose Maria Fiandor (9 out of 11 patents)

12. Stuart B Levy (8 out of 34 patents)

13. Laura McIntyre (8 out of 9 patents)

14. Sean M Johnston (7 out of 10 patents)

15. Joel Berniac (7 out of 7 patents)

Core Competencies:

Tetracycline Compounds

Minocycline Compounds

Biodefense

Community-Acquired Bacterial Pneumonia

Urinary Tract Infection Treatment

RNA Modulation

Inflammatory Skin Disorders

Oral Bioavailability

Spinal Muscular Atrophy

Antifungal Agents

Malaria Treatment

Bacterial Efflux Pumps

71 patents: Sort by Forward Citations

1. 12161655 - Methods of treating mycobacterial infections using tetracycline compounds (2024-12-10),

2. 11129839 - Minocycline compounds for biodefense (2021-09-28),

3. 10835542 - 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) (2020-11-17),

4. 10383884 - 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) (2019-08-20),

5. 10238670 - 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (UTI) treatment (2019-03-26),

6. 10124014 - Minocycline compounds and methods of use thereof (2018-11-13),

7. 10111890 - 9-aminomethyl minocycline compounds and uses thereof (2018-10-30),

8. 9724358 - Minocycline compounds and methods of use thereof (2017-08-08),

9. 9562003 - Methods of using substituted tetracycline compounds to modulate RNA (2017-02-07),

10. 9533943 - Substituted tetracycline compounds (2017-01-03),

11. 9522872 - Methods for synthesizing substituted tetracycline compounds (2016-12-20),

12. 9481639 - Substituted tetracycline compounds for treatment of inflammatory skin disorders (2016-11-01),

13. 9434680 - Methods for synthesizing and purifying aminoalkyl tetracycline compounds (2016-09-06),

14. 9365500 - 9-aminomethyl substituted minocycline compounds (2016-06-14),

15. 9314475 - Oral and injectable formulations of tetracycline compounds (2016-04-19),

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies to improve the lives of patients suffering from serious infections. With a strong commitment to antibiotic stewardship, Paratek aims to provide innovative solutions to combat the rapidly rising antibiotic resistance crisis. The company's portfolio includes FDA-approved antibiotics, as well as investigational drugs in various stages of development. By combining cutting-edge science with a patient-centric approach, Paratek Pharmaceuticals strives to address the urgent unmet medical needs in infectious disease management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

71 Patents

#35 in Boston, MA

#280 in Massachusetts

#4,995 in US

#10,222 in the World

Boston, MA, United States of America

Paratek Pharmaceuticals, Inc.

Forward Citations = 879

62 inventors:

Mark L Nelson (38 out of 70 patents)

Roger Frechette (21 out of 24 patents)

Beena Bhatia (16 out of 18 patents)

4. Todd Bowser (15 out of 16 patents)

5. Mohamed Y Ismail (15 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…